These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 5305932)
61. [The effect of noracycline administered in menstruation disorders on certain biological functions of the female organism. Effects on the protein metabolism]. Jabloński K; Giermańska T; Filc-Bauer A Pol Tyg Lek; 1970 May; 25(18):635-7. PubMed ID: 5429830 [No Abstract] [Full Text] [Related]
62. [Clinical study of a synthetic progestative agent in small doses: Ovariostat Organon]. Gaudefroy M J Sci Med Lille; 1966 Mar; 84(3):127-36. PubMed ID: 5931056 [No Abstract] [Full Text] [Related]
63. [Our clinical experience with ethynodiol diacetate, alone or combined in variable doses with mestranol]. Colin R Gynecol Obstet (Paris); 1966; 65(4):537-43. PubMed ID: 5971381 [No Abstract] [Full Text] [Related]
64. [Apropos of the treatment of acne with a synthetic estroprogestative agent]. Jamain C; Cattin R Bull Soc Fr Dermatol Syphiligr; 1966; 73(2):161-3. PubMed ID: 4223751 [No Abstract] [Full Text] [Related]
66. Menstrual regulation in women with von Willebrand's disease. Hicks S; DeLoughery T; Edelman A Int J Gynaecol Obstet; 2008 Jul; 102(1):80-1. PubMed ID: 18313057 [No Abstract] [Full Text] [Related]
67. [Hemarthroses due to coagulopathies other than hemophilia]. David-Chaussé J; Ducassou N Bord Med; 1971 Jan; 4(1):43-6 passim. PubMed ID: 5313760 [No Abstract] [Full Text] [Related]
69. [Effect of noracycline administered in menstruation disorders on various biological functions of the female organism. The secretion of ovarian hormones]. Jabloński K; Zymek-Giermańska T; Filc-Bauer A Pol Tyg Lek; 1971 Apr; 26(14):505-7. PubMed ID: 5581640 [No Abstract] [Full Text] [Related]
70. Menorrhagia in adolescents with inherited bleeding disorders. Chi C; Pollard D; Tuddenham EG; Kadir RA J Pediatr Adolesc Gynecol; 2010 Aug; 23(4):215-22. PubMed ID: 20471874 [TBL] [Abstract][Full Text] [Related]
71. [Hemostatic effect of a combination of mestranol and chlorsuperlutin in dysfunctional bleeding]. Vorísek P; Pospísil J; Horský J; Presl J Cesk Gynekol; 1969 Sep; 34(7):410-2. PubMed ID: 5809757 [No Abstract] [Full Text] [Related]
73. [Handling of a synthetic progestative in a psychiatric milieu]. Dubor P; Favre-Tissot M; Guyotat J; Haour P; Simonnet ; Vantheemsche G J Med Lyon; 1966 Oct; 47(106):1379-85. PubMed ID: 5928220 [No Abstract] [Full Text] [Related]
74. [Clinical experiences with gestagen therapy of various gynecologic diseases]. György G; László J Orv Hetil; 1967 Jun; 108(25):1169-71. PubMed ID: 6077686 [No Abstract] [Full Text] [Related]
75. Management quandary. Menorrhagia in a teenager: Von Willebrand disease type 1. Braverman PK; Breech L J Pediatr Adolesc Gynecol; 2004 Feb; 17(1):61-4. PubMed ID: 15010043 [No Abstract] [Full Text] [Related]
76. Effect of progestational compounds on ovarian endometriosis. Plate WP Ned Tijdschr Verloskd Gynaecol; 1966 Aug; 66(4):275-83. PubMed ID: 5946696 [No Abstract] [Full Text] [Related]
77. [Estroprogestinic associations in the preclimacteric syndrome: blood coagulation problems]. Schubert L; Giarola P; Gibelli A; Iurlaro F G Gerontol; 1969 Nov; 17(11):1059-66. PubMed ID: 5397790 [No Abstract] [Full Text] [Related]
78. The spectrum of haemostatic characteristics of women with unexplained menorrhagia. Miller CH; Philipp CS; Stein SF; Kouides PA; Lukes AS; Heit JA; Byams VR; Dowling NF; Kulkarni R Haemophilia; 2011 Jan; 17(1):e223-9. PubMed ID: 21040234 [TBL] [Abstract][Full Text] [Related]
79. A step-by-step guide to the diagnosis of bleeding disorders. Bithell TC Med Times; 1979 Nov; 107(11):43-52. PubMed ID: 317508 [No Abstract] [Full Text] [Related]
80. Treatment of menorrhagia with epsilon aminocaproic acid. A double blind investigation. Nilsson L; Rybo G Acta Obstet Gynecol Scand; 1965; 44(3):467-73. PubMed ID: 5324474 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]